Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3ZW0K18
Stock Name / FundiShares S&P 500 EUR Hedged UCITS ETF (Acc)
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerIBCF(EUR) F
ETF TickerIUES.AS(EUR) CXE
ETF TickerIUSE.L(EUR) CXE
ETF TickerIUSE.MI(EUR) CXE
ETF TickerIUSEz(EUR) CXE
ETF TickerIUSE(EUR) ETF Plus

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares S&P 500 EUR Hedged UCITS ETF (Acc) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
2025-11-11 (Tuesday)15,248USD 8,870,667REGN holding increased by 224345USD 8,870,6670USD 224,345 USD 581.759 USD 567.046
2025-11-10 (Monday)15,248USD 8,646,322REGN holding decreased by -17335USD 8,646,3220USD -17,335 USD 567.046 USD 568.183
2025-11-07 (Friday)15,248REGN holding decreased by -44USD 8,663,657REGN holding increased by 91417USD 8,663,657-44USD 91,417 USD 568.183 USD 560.57
2025-11-06 (Thursday)15,292USD 8,572,240REGN holding decreased by -9477USD 8,572,2400USD -9,477 USD 560.57 USD 561.19
2025-11-05 (Wednesday)15,292REGN holding decreased by -154USD 8,581,717REGN holding increased by 140986USD 8,581,717-154USD 140,986 USD 561.19 USD 546.467
2025-11-04 (Tuesday)15,446USD 8,440,731REGN holding decreased by -167186USD 8,440,7310USD -167,186 USD 546.467 USD 557.291
2025-11-03 (Monday)15,446USD 8,607,917REGN holding decreased by -114750USD 8,607,9170USD -114,750 USD 557.291 USD 564.72
2025-10-31 (Friday)15,446REGN holding decreased by -827USD 8,722,667REGN holding decreased by -481063USD 8,722,667-827USD -481,063 USD 564.72 USD 565.583
2025-10-30 (Thursday)16,273USD 9,203,730REGN holding increased by 94673USD 9,203,7300USD 94,673 USD 565.583 USD 559.765
2025-10-29 (Wednesday)16,273USD 9,109,057REGN holding decreased by -26212USD 9,109,0570USD -26,212 USD 559.765 USD 561.376
2025-10-28 (Tuesday)16,273REGN holding increased by 24USD 9,135,269REGN holding increased by 961403USD 9,135,26924USD 961,403 USD 561.376 USD 503.038
2025-10-27 (Monday)16,249USD 8,173,866REGN holding increased by 96187USD 8,173,8660USD 96,187 USD 503.038 USD 497.119
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00B3ZW0K18

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-07SELL-44 568.183* 576.89 Profit of 25,383 on sale
2025-11-05SELL-154646.895628.000 629.890USD -97,003 577.03 Loss of -8,140 on sale
2025-10-31SELL-827659.760645.000 646.476USD -534,636 577.32 Loss of -57,189 on sale
2025-10-28BUY24654.480655.700 655.578USD 15,734 577.54
2025-10-14SELL-144572.600576.180 575.822USD -82,918 581.52 Profit of 821 on sale
2025-10-02BUY48600.000605.410 604.869USD 29,034 582.63
2025-09-30SELL-48562.270574.040 572.863USD -27,497 583.52 Profit of 511 on sale
2025-09-16BUY24575.060579.400 578.966USD 13,895 587.02
2025-09-15BUY24572.590573.690 573.580USD 13,766 587.55
2025-08-21BUY23598.160605.180 604.478USD 13,903 589.54
2025-08-20SELL-46591.010596.920 596.329USD -27,431 589.99 Loss of -292 on sale
2025-08-13BUY46561.550565.500 565.105USD 25,995 591.17
2025-08-12BUY23556.550562.740 562.121USD 12,929 591.79
2025-08-08SELL-23563.000567.690 567.221USD -13,046 593.07 Profit of 594 on sale
2025-08-05BUY46569.900579.820 578.828USD 26,626 594.28
2025-08-04SELL-92571.540577.210 576.643USD -53,051 594.85 Profit of 1,675 on sale
2025-08-01SELL-23558.870583.280 580.839USD -13,359 595.48 Profit of 337 on sale
2025-07-31BUY69545.460558.130 556.863USD 38,424 596.16
2025-07-30BUY23554.580563.590 562.689USD 12,942 596.81
2025-07-18SELL-69542.520550.890 550.053USD -37,954 601.08 Profit of 3,521 on sale
2025-07-16SELL-46547.930558.350 557.308USD -25,636 602.62 Profit of 2,084 on sale
2025-07-10BUY23559.760566.370 565.709USD 13,011 605.62
2025-07-07BUY46538.110547.590 546.642USD 25,146 608.25
2025-07-02BUY23547.740551.500 551.124USD 12,676 611.00
2025-06-24BUY46522.270527.450 526.932USD 24,239 616.39
2025-06-23BUY23511.920516.180 515.754USD 11,862 617.54
2025-06-18BUY23513.580519.170 518.611USD 11,928 621.05
2025-06-17BUY23508.860523.010 521.595USD 11,997 622.28
2025-06-05SELL-46483.070491.770 490.900USD -22,581 632.42 Profit of 6,510 on sale
2025-06-03BUY46487.860501.110 499.785USD 22,990 635.45
2025-05-28BUY253591.850606.000 604.585USD 152,960 640.18
2025-05-27BUY69603.260608.170 607.679USD 41,930 641.01
2025-05-22SELL-23596.850605.500 604.635USD -13,907 643.81 Profit of 901 on sale
2025-05-21SELL-23604.620617.520 616.230USD -14,173 644.68 Profit of 654 on sale
2025-05-20SELL-46614.790615.450 615.384USD -28,308 645.46 Profit of 1,384 on sale
2025-05-19SELL-46596.540598.560 598.358USD -27,524 646.39 Profit of 2,209 on sale
2025-05-15BUY23584.990585.260 585.233USD 13,460 648.31
2025-05-14BUY46571.360580.560 579.640USD 26,663 649.45
2025-05-13BUY69574.160575.050 574.961USD 39,672 650.57
2025-05-12BUY138575.630577.990 577.754USD 79,730 651.67
2025-05-09BUY69527.780552.840 550.334USD 37,973 653.21
2025-05-02BUY23605.610615.610 614.610USD 14,136 659.61
2025-04-30BUY960598.760600.200 600.056USD 576,054 662.02
2025-04-28BUY22610.860614.830 614.433USD 13,518 664.63
2025-04-25SELL-22602.640602.790 602.775USD -13,261 665.87 Profit of 1,388 on sale
2025-04-24BUY66599.760601.280 601.128USD 39,674 667.15
2025-04-23BUY22587.850603.770 602.178USD 13,248 668.54
2025-04-22BUY22585.490587.100 586.939USD 12,913 670.04
2025-04-16SELL-22549.280561.830 560.575USD -12,333 677.07 Profit of 2,563 on sale
2025-04-15BUY22557.910575.200 573.471USD 12,616 678.90
2025-04-14BUY44571.060574.720 574.354USD 25,272 680.66
2025-04-11BUY44554.180555.530 555.395USD 24,437 682.60
2025-04-10BUY22546.390571.990 569.430USD 12,527 684.58
2025-04-09BUY22576.720580.730 580.329USD 12,767 686.25
2025-04-08BUY44556.810586.030 583.108USD 25,657 688.08
2025-04-07SELL-22572.780591.540 589.664USD -12,973 689.80 Profit of 2,203 on sale
2025-04-04SELL-132573.450612.990 609.036USD -80,393 691.59 Profit of 10,897 on sale
2025-04-01SELL-44617.000641.240 638.816USD -28,108 694.16 Profit of 2,435 on sale
2025-03-31SELL-44634.230640.720 640.071USD -28,163 695.33 Profit of 2,432 on sale
2025-03-28SELL-44637.360642.970 642.409USD -28,266 696.52 Profit of 2,381 on sale
2025-03-25BUY22634.140662.570 659.727USD 14,514 700.19
2025-03-21SELL-88658.480661.000 660.748USD -58,146 702.30 Profit of 3,656 on sale
2025-03-20SELL-66662.620674.830 673.609USD -44,458 703.39 Profit of 1,965 on sale
2025-03-18BUY132664.960678.270 676.939USD 89,356 705.58
2025-03-11SELL-22718.160747.700 744.746USD -16,384 710.49 Loss of -754 on sale
2025-03-10SELL-66744.830748.290 747.944USD -49,364 710.80 Loss of -2,452 on sale
2025-03-07SELL-154707.510729.750 727.526USD -112,039 711.60 Loss of -2,453 on sale
2025-03-05SELL-66687.150692.790 692.226USD -45,687 712.58 Profit of 1,344 on sale
2025-03-03SELL-88684.870704.640 702.663USD -61,834 714.40 Profit of 1,032 on sale
2025-02-27SELL-22702.780721.000 719.178USD -15,822 715.57 Loss of -79 on sale
2025-02-19BUY22685.660688.670 688.369USD 15,144 719.60
2025-02-18BUY44680.000689.950 688.955USD 30,314 720.71
2025-02-13BUY44674.270677.690 677.348USD 29,803 724.58
2025-02-05SELL-176716.720729.250 727.997USD -128,127 730.58 Profit of 455 on sale
2025-02-04BUY22697.050709.980 708.687USD 15,591 731.70
2025-01-31BUY631672.980688.000 686.498USD 433,180 735.02
2025-01-29BUY21687.270697.570 696.540USD 14,627 738.20
2025-01-28BUY21686.330690.300 689.903USD 14,488 739.86
2025-01-24BUY63675.790693.840 692.035USD 43,598 743.88
2025-01-23BUY147694.640696.190 696.035USD 102,317 745.57
2025-01-22BUY105680.030699.880 697.895USD 73,279 747.68
2025-01-21BUY21687.800692.930 692.417USD 14,541 749.69
2025-01-16BUY126693.230706.540 705.209USD 88,856 756.16
2025-01-15BUY21703.430712.600 711.683USD 14,945 758.05
2025-01-10BUY21696.880724.730 721.945USD 15,161 764.16
2024-12-10BUY22778.500791.490 790.191USD 17,384 768.01
2024-12-09BUY88788.000800.990 799.691USD 70,373 768.76
2024-12-05SELL-44767.900768.020 768.008USD -33,792 771.25 Profit of 143 on sale
2024-12-04BUY66754.260756.130 755.943USD 49,892 773.15
2024-12-03SELL-110749.570770.000 767.957USD -84,475 775.31 Profit of 808 on sale
2024-12-02BUY44762.340763.890 763.735USD 33,604 777.05
2024-11-29SELL-551750.220754.510 754.081USD -415,499 779.62 Profit of 14,072 on sale
2024-11-25BUY46749.510757.860 757.025USD 34,823 791.26
2024-11-22SELL-23738.000751.400 750.060USD -17,251 795.18 Profit of 1,038 on sale
2024-11-21SELL-23744.500757.560 756.254USD -17,394 799.53 Profit of 995 on sale
2024-11-18BUY115762.000762.700 762.630USD 87,702 815.29
2024-11-12BUY23821.000831.000 830.000USD 19,090 817.88
2024-11-08BUY161828.420830.730 830.499USD 133,710 824.29
2024-11-07BUY46824.480832.530 831.725USD 38,259 829.03
2024-11-06BUY23816.650844.510 841.724USD 19,360 834.75
2024-10-31SELL-492838.200883.150 878.655USD -432,298 868.25 Loss of -5,118 on sale
2024-10-29BUY24927.330932.380 931.875USD 22,365 872.97
2024-10-28BUY24928.610943.270 941.804USD 22,603 875.89
2024-10-25BUY24933.020943.830 942.749USD 22,626 879.52
2024-10-24BUY24928.900952.020 949.708USD 22,793 885.92
2024-10-23SELL-48941.390959.600 957.779USD -45,973 892.05 Loss of -3,155 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.